Relevant bibliographies by topics / Chronic inflammatory rheumatisms

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Chronic inflammatory rheumatisms'

Author: Grafiati
Published: 26 April 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Chronic inflammatory rheumatisms.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Chronic inflammatory rheumatisms"

1

Makita, Chantal, Norbert N’Soundhat, Charles Ngabou, and Honoré Ntsiba. "Ocular Reactions during Chronic Inflammatory Rheumatisms." Ophthalmology Research: An International Journal 8, no. 2 (February 6, 2018): 1–5. http://dx.doi.org/10.9734/or/2018/39234.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Esseghir, S., L. Souabni, K. Ben Abdelghani, K. Salma, C. Salma, S. Belhadj, L. Ahmed, and Z. Leith. "AB1087 Tuberculosis infections and chronic inflammatory rheumatisms:." Annals of the Rheumatic Diseases 71, Suppl 3 (June 2013): 700.7–700. http://dx.doi.org/10.1136/annrheumdis-2012-eular.1086.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hamdi, O., M. Sellami, S. Miladi, A. Fazaa, L. Souabni, K. Ouenniche, S. Kassab, S. Chekili, K. Ben Abdelghani, and A. Laatar. "AB0886-HPR ASSESSMENT OF SEASONAL VARIATIONS ON CHRONIC INFLAMMATORY RHEUMATISMS ACTIVITY." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 1466.2–1467. http://dx.doi.org/10.1136/annrheumdis-2021-eular.412.

Full text
Abstract:
Background:Although rheumatoid arthritis (RA) and spondyloarthritis (SA) activities have been described to vary under the influence of several factors, little is known about the influence of seasonality on the activity of chronic inflammatory rheumatisms.Objectives:To assess the influence of seasonality on the activity of chronic inflammatory rheumatisms.Methods:We conducted a cross-sectional study involving patients with RA (2010 ACR/EULAR criteria) and SA (2009 ASAS criteria). Chronic inflammatory rheumatisms activity was assessed during the summer (June-September) and winter (December-February) using clinical parameters including the Patient’s Global Assessment of disease activity (PGA), 10-cm Visual Analog Scale (VAS) pain score, morning stiffness, nocturnal awakenings, and joint count for RA (tender joint count (TJC) and swollen joint count (SJC)); biological parameters including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP); disease activity scores including the SDAI, CDAI and DAS28for RA, BASDAI and ASDASCRP for SA. An analysis of variance (ANOVA) was used to assess the statistical relationship between seasonality and rheumatisms activities.Results:We enrolled 175 patients (100 RA and 75 SA) with a sex ratio of 0.5 and a mean age of 57.75 ± 10.53 years [23-83]. The mean chronic inflammatory rheumatisms duration was 12.38 ± 4.6 years. RA was erosive in 91% of cases. Rheumatoid factor and anti-citrullinated peptides antibodies were positive respectively in 84% and 85% of cases. Seventy-five percent of RA patients were on corticosteroids with a mean dose of 10.14 mg/day of prednisone equivalent and 79% of SA patients were on non-steroidal anti-inflammatory drugs. Eighty percent of our patients were treated with conventional synthetic DMARD and 44% with biological DMARD. Small joints were more affected than large joints regardless of the season in RA patients (p=0.05). The following parameters were higher in winter than in summer in RA patients: mean PGA 4.73 vs 4.64 (p=0.01); mean morning stiffness 1.6 vs 1.1 (p=0.01); mean SJC 8.7 vs 7.5 (p=0.01); mean DAS28 ESR 4.56 vs 3.99 (p= 0.05); mean DAS28 CRP 4.6 vs 3.41 (p= 0.05), mean SDAI 21.8 vs 19.5 (p= 0.05); mean CDAI 20.5 vs 18.75 (p= 0.01) and mean ESR 45.6mm/h vs 38.2 mm/h (p=0.01). As for SA, the following parameters were higher in winter than in summer: mean morning stiffness 2 vs 1.4 (p= 0.01); mean ASDASCRP 3.9 vs 3.1 (p= 0.01) and mean BASDAI 6.2 vs 4.9 (p= 0.05). However, we found no statistically significant correlation between seasonal changes and VAS pain score, nocturnal awakenings, TJC, and CRP.Conclusion:Chronic inflammatory rheumatisms activity was higher in winter. Health care professionals should take seasonal changes into account in order to improve therapeutic care.Disclosure of Interests:None declared
APA, Harvard, Vancouver, ISO, and other styles
4

Hamdi, O., S. Jemmali, S. Boussaid, S. Rahmouni, S. Rekik, H. Sahli, and M. Elleuch. "POS1515-HPR CONJUGAL RELATIONSHIPS IN MARRIED PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATISMS." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1102.2–1103. http://dx.doi.org/10.1136/annrheumdis-2022-eular.428.

Full text
Abstract:
BackgroundThe consequences of chronic inflammatory rheumatisms (CIR) on the sexuality and the relationships between the subject and his/her partner are still underestimated and insufficiently studied.ObjectivesThe aim of this study was to investigate the impact of CIR on conjugal relationships.MethodsWe conducted a cross-sectional study involving patients with rheumatoid arthritis (RA) (2010 ACR/EULAR criteria) and spondyloarthritis (SpA) (2009 ASAS criteria). All the patients included in the study were married. We collected demographic data, and participants were asked to complete a questionnaire on their conjugal relationships.ResultsWe enrolled 75 patients (40 RA and 35 SpA) with a sex ratio of 0.4 and a mean age of 55.35 ± 9.81 years [22-85]. The mean chronic CIR duration was 11.85 ± 3.4 years. The mean duration of marriage was 9.5 ± 2.6 years. The mean age at marriage was 27 ± 6.41 years [19-33]. The mean number of off-springs was 4. Forty-nine percent of patients and 22.3% of the partners had a profession, respectively. Forty one percent of the partners had a chronic disease: diabetes (n=12), hypertension (n=10), dyslipidemia (n=7), CIR (n=7), coronary disease (n=3), and other conditions (n=5). A psychiatric illness was noted in 22.6% of cases: depression (n=9), anxiety (n=6), and bipolar disorder (n=2). Sixty-four percent of patients consider their spouses sympathetic to their illness. Eighty-nine percent of participants have noticed a change in their life as a couple before and after the CIR onset. According to 64% of participants, the CIR had a negative impact on their married lives. The spouses’ emotional reactions to the disease were as follows: indifference (30.6%), denial (29.3%), anger (26.6%), and fear (13.6%). Patients reported being accompanied by their spouses to their medical appointments in 36% of cases, and 40% of them were asked questions by their spouses about their disease and treatment. The CIR has resulted in the termination of the marriage in 2.6% of cases.ConclusionPatients suffering from chronic diseases such as CIR are more frequently exposed to difficulties in their conjugal relationships. The disease has thus important consequences on the subject’s quality of life, emotional and interpersonal state. A better compliance with the chronic disease and its treatment may improve the couples’ relationships.Disclosure of InterestsNone declared
APA, Harvard, Vancouver, ISO, and other styles
5

Tubery, A., P. Fesler, G. Du Cailar, J. Morel, J. Bousquet, B. Combe, and C. Daien. "Interest of a systematic screening of comorbidities in chronic inflammatory rheumatisms." Annals of Physical and Rehabilitation Medicine 58 (September 2015): e120. http://dx.doi.org/10.1016/j.rehab.2015.07.289.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Arabi, H., H. Tebaa, A. Mougui, and I. El Bouchti. "AB0320 SACROILIITIS AND ACPA POSITIVE: IS THIS AN ASSOCIATION OF RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS? ABOUT 16 CASES." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1343.3–1344. http://dx.doi.org/10.1136/annrheumdis-2023-eular.6488.

Full text
Abstract:
BackgroundRheumatoid arthritis (RA) and spondyloarthritis (SpA) in particular psoriatic arthritis (RP) are two distinct inflammatory rheumatisms having in common destructive peripheral involvement.ObjectivesWe report a series of chronic inflammatory rheumatism with features of RA and SpA.MethodsDescriptive retrospective study including patients with chronic inflammatory rheumatism, collected in the rheumatology department over a period of 10 years (2009-2019).Results16 patients were included. The average age was 45.94 ± 12.10 years [28-71], with a female predominance of 87.5%. The mean age at onset of symptoms was 34.69 ± 12.71 years [14-57]. The disease duration was 11.25 ± 10.44 years. History was dominated by hepatic steatosis in 25%, diabetes in 18.8%, hypertension and smoking in 12.5%. A history of familial rheumatism and cutaneous psoriasis was found in only one patient. The revealing symptomatology was dominated by chronic polyarthritis in 75%, polyarthralgia in 18.8% and mono-arthritis in one case. Deformities were described in 43.8%. On the immunological assessment, the mean ACPA was 191.25 ± 155.68 [36-500]. Rheumatoid factor and Anti-nuclear antibodies were positive in 50% and 37.5% respectively. HLA B27 was done in 2 patients, 1 of whom was positive. Sjögren’s syndrome was present in 37.5% of patients. A biological inflammatory syndrome was found in the majority of patients with an average ESR and CRP of 37.38 and 20.41 respectively. Radiographic sacroiliitis was noted in 56.3%, and the rest were non-radiographic. Syndesmophytes were noted in 3 patients (18.8%). Coxitis was present in 12.6%. Structural damage in 81.3% made of erosions, geodes and pinching with reconstruction images in 4 patients.Patients were treated with corticosteroid therapy in 87.5%, methotrexate in 62.5%, sulfasalazine in 43.8%, and biotherapy in 25% of cases with anti-TNF alpha type.ConclusionThese associations pose difficulties in diagnosis and management. A more in-depth study of these patients can help with an accurate diagnosis and therefore with optimal management.REFERENCES:NIL.Acknowledgements:NIL.Disclosure of InterestsNone Declared.
APA, Harvard, Vancouver, ISO, and other styles
7

Hamdi, O., S. Jemmali, W. Kammoun, S. Boussaid, S. Rahmouni, S. Rekik, H. Sahli, and M. Elleuch. "POS1516-HPR CHRONIC INFLAMMATORY RHEUMATISMS: DOES PERIODIC FASTING REDUCE THE DISEASE ACTIVITY?" Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1103.1–1103. http://dx.doi.org/10.1136/annrheumdis-2022-eular.429.

Full text
Abstract:
BackgroundMany experimental studies have emphasized the role of periodic fasting in the adaptive responses that reduce inflammation.ObjectivesOur purpose was to assess the impact of periodic fasting on the activity of chronic inflammatory rheumatisms (CIR).MethodsWe conducted a cross-sectional study involving patients with rheumatoid arthritis (RA) (2010 ACR/EULAR criteria) and spondyloarthritis (SpA) (2009 ASAS criteria). CIR activity was assessed during the period of Ramadan (periodic fasting) and three months following Ramadan using clinical parameters including the Patient’s Global Assessment of disease activity (PGA), 10-cm Visual Analog Scale (VAS) pain score, morning stiffness, nocturnal awakenings, and joint count for RA (tender joint count (TJC) and swollen joint count (SJC)); biological parameters including C-reactive protein (CRP); disease activity scores including the SDAI, CDAI and DAS28 CRP for RA, BASDAI and ASDASCRP for SpA. An analysis of variance (ANOVA) was used to assess the statistical relationship between fasting and CIR activity.ResultsWe enrolled 75 patients (40 RA and 35 SpA) with a sex ratio of 0.4 and a mean age of 55.35 ± 9.81 years [22-85]. The mean chronic CIR duration was 11.85 ± 3.4 years. RA was erosive in 92% of cases. Rheumatoid factor and anti-citrullinated peptides antibodies were positive respectively in 82% and 84% of cases. Seventy-five percent of RA patients were on corticosteroids with a mean dose of 10.20 mg/day of prednisone equivalent, and 81% of SpA patients were on non-steroidal anti-inflammatory drugs. Eighty-three percent of our patients were treated with conventional synthetic DMARD, and 40% with biological DMARD. The following parameters were lower in the month of Ramadan compared to the period following Ramadan in RA patients: mean PGA 4.3 vs 4.6 (p=0.01); mean morning stiffness 1.1 vs 1.5 (p=0.01); mean SJC 4.7 vs 8.5 (p=0.01); mean DAS28 CRP 3.56 vs 4.25 (p= 0.05); mean CDAI 17.5 vs 20.35 (p= 0.01), and mean SDAI 13.87 vs 18.44 (p=0.01). As for SpA, the following parameters were lower in the month of Ramadan compared to the period following Ramadan: mean morning stiffness 1.3 vs 2.1 (p= 0.01); mean ASDASCRP 2.9 vs 3.3 (p= 0.01), and mean BASDAI 3.6 vs 4.9 (p= 0.05). However, we found no statistically significant correlation between periodic fasting and VAS pain score, nocturnal awakenings, TJC, and CRP.ConclusionOur study concluded that periodic fasting was associated to a lower CIR activity. The incorporation of periodic fasting may promote optimal health and reduce the activity of some chronic inflammatory diseases.Disclosure of InterestsNone declared
APA, Harvard, Vancouver, ISO, and other styles
8

Daien, C. I., A. Tubery, P. Fesler, G. Du Cailar, J. Morel, J. Bousquet, and B. Combe. "SAT0107 Interest of a Systematic Screening of Comorbidities in Chronic Inflammatory Rheumatisms." Annals of the Rheumatic Diseases 74, Suppl 2 (June 2015): 688.3–689. http://dx.doi.org/10.1136/annrheumdis-2015-eular.4722.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

S, Bouomrani. "Acute polyarthritis revealing celiac disease of the elderly." General Medicine and Clinical Practice 1, no. 1 (September 3, 2018): 01–03. http://dx.doi.org/10.31579/2639-4162/004.

Full text
Abstract:
Introduction: Celiac disease (CD) is an autoimmune disease that typically occurs in childhood and young age. Late-onset forms (after 60 years) are rare and often underestimated in current medical practice, as is joint damage during this disease. We report an original case of CD in an elderly patient revealed by acute polyarthritis. Observation: A 62-year-old patient with no significant pathological history was explored for acute polyarthritis of both large and small joints. The physical examination noted synovitis of the hands and wrists without articular deformities, and a marked mucocutaneous pallor. The biology revealed a microcytic anemia at 8 g/dl with stigmas of malabsorption (low cholesterol and hypocalcemia). No inflammatory syndrome was noted. Joint X-rays were without abnormalities. Immunological tests for chronic inflammatory rheumatisms were negative. Gastroduodenal fibroscopy was performed and histological examination of duodenal biopsies showed diffuse villous atrophy with marked inflammatory infiltrate. Anti- endomysium and anti-transglutaminase antibodies were positive confirming the diagnosis of CD. Under gluten-free diet, the evolution was favorable with totally disappearance of articular signs. Conclusion: Joint manifestations during CD are rare. The revealing forms are exceptional and can make a differential diagnosis with chronic inflammatory rheumatism, in particular that associations with CD was described. CD deserves to be evoked in front of any unexplained arthritis of the elderly, even without any specific digestive symptomatology of this disease.
APA, Harvard, Vancouver, ISO, and other styles
10

Dobi, Anthony, Philippe Gasque, Pascale Guiraud, and Jimmy Selambarom. "Irinotecan (CPT-11) Canonical Anti-Cancer Drug Can also Modulate Antiviral and Pro-Inflammatory Responses of Primary Human Synovial Fibroblasts." Cells 10, no. 6 (June 8, 2021): 1431. http://dx.doi.org/10.3390/cells10061431.

Full text
Abstract:
Alphaviruses are a group of arboviruses that generate chronic inflammatory rheumatisms in humans. Currently, no approved vaccines or antiviral therapies are available to prevent or treat alphavirus-induced diseases. The aim of this study was to evaluate the repositioning of the anti-cancer molecule irinotecan as a potential modulator of the antiviral and inflammatory responses of primary human synovial fibroblasts (HSF), the main stromal cells of the joint synovium. HSF were exposed to O’nyong-nyong virus (ONNV) and polyinosinic-polycytidylic acid (PIC) to mimic, respectively, acute and chronic infectious settings. The cytokine IL-1β was used as a major pro-inflammatory cytokine to stimulate HSF. Quantitative RT-PCR analysis revealed that irinotecan at 15 µM was able to amplify the antiviral response (i.e., interferon-stimulated gene expression) of HSF exposed to PIC and reduce the expression of pro-inflammatory genes (CXCL8, IL-6 and COX-2) upon IL-1β treatment. These results were associated with the regulation of the expression of several genes, including those encoding for STAT1, STAT2, p53 and NF-κB. Irinotecan did not modulate these responses in both untreated cells and cells stimulated with ONNV. This suggests that this drug could be therapeutically useful for the treatment of chronic and severe (rather than acute) arthritis due to viruses.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Chronic inflammatory rheumatisms"

1

Mussel, Stéphanie. "Améliorer les ressources de patients atteints de maladie chronique en ciblant les croyances liées aux traitements, les besoins psychologiques fondamentaux, et les compétences de pleine conscience." Electronic Thesis or Diss., Université de Lorraine, 2024. https://docnum.univ-lorraine.fr/ulprive/DDOC_T_2024_0271_DVORSAK.pdf.

Full text
Abstract:
Introduction : Les maladies rhumatologiques, classées 3ème en termes d’incapacités (Cross, Smith, Hoy et al., 2014), connaissent un retentissement majeur en santé. Les rhumatismes inflammatoires chroniques (RIC) en font partie. Les patients qui en sont atteints sont sujets à des douleurs récurrentes de type fibromyalgie et des comorbidités anxio-dépressives. Avec une symptomatologie très différente, le diabète connaît également un fort retentissement sociétal : 7ème cause de mortalité selon l’OMS en 2003, possibles apparitions de complications graves et émergence d’émotions négatives, de troubles anxieux et dépressifs. Les RIC autant que le diabète nécessitent pour les patients, de mettre en place de nouveaux comportements et de les maintenir dans la durée. Dans leur prise en charge, des recommandations leur sont faites par rapport au traitement, mais aussi à leur mode de vie. Il peut être difficile pour eux d’y adhérer. Une prise en charge psychologique basée sur la pleine conscience peut favoriser chez eux, le développement d’émotions positives, de stratégies d’adaptation et de capacités d’acceptation, ainsi que la satisfaction de besoins psychologiques fondamentaux à leur équilibre. L’objectif de cette thèse est d’identifier des leviers d’action parmi les compétences de pleine conscience, la satisfaction des besoins psychologiques fondamentaux et les croyances liées aux traitements, afin de proposer aux professionnels qui les accompagnent, des façons d’optimiser leur prise en charge.Méthode : La première partie de la thèse a consisté à adapter dans le contexte de la maladie chronique, une échelle de mesure de la satisfaction et frustration des besoins psychologiques issus du modèle de l’autodétermination. (Chen et al., 2015). L’outil de 24 items évalués par une échelle de Likert à 5 points a été testé sur 2 échantillons de sujets recrutés en ligne : un groupe de patients atteints de RIC (polyarthrite rhumatoïde, spondylarthrite ankylosante, ou rhumatisme psoriasique) et un groupe de patients diabétiques. Les propriétés psychométriques de l’échelle ont été testées par des analyses quantitatives fondées sur deux théories : la théorie classique du test, et la théorie basée sur le modèle de la réponse à l’item.L’échelle validée a ensuite été utilisée avec d’autres variables d’intérêt comme les compétences de pleine conscience, les croyances liées aux traitements et les affects anxiodépressifs, dans des analyses de régressions linéaires multiples, afin d’identifier leur impact sur la satisfaction de vie, la qualité de vie et de l’adhésion, pour pouvoir proposer des interventions basées sur les leviers identifiés.Résultats : l’échelle adaptée au contexte de la maladie chronique est un instrument fiable et valide, qui peut servir tant dans la recherche que dans la pratique clinique. Elle comporte 8 dimensions, et distingue deux populations en relations avec les patients : leurs proches et les professionnels de santé. La satisfaction de vie peut être améliorée en soutenant l’autonomie des patients, et en prenant en considération les affects dépressifs des patients. La qualité de vie peut être améliorée par la satisfaction du besoin de compétence, en réduisant les affects dépressifs, et la frustration des besoins d’autonomie et de compétence. Les affects anxieux ont un impact ambivalent sur la qualité de vie, améliorant sa dimension physique et altérant sa dimension mentale. L’adhésion au traitement peut être améliorée grâce aux compétences de pleine conscience, aux croyances liées aux traitements et en réduisant la frustration liée aux relations avec les proches.Conclusion : développer les compétences de pleine conscience, soutenir l’autonomie des patients, et lever les obstacles liés aux représentations sur les traitements confortent l’intérêt à porter aux approches intégratives pour améliorer la prise en charge globale des patients
Introduction: Rheumatological diseases, ranked 3rd in terms of disability (Cross, Smith, Hoy et al., 2014), have a major impact on health. Chronic inflammatory rheumatism (CIR) is one of them. Patients suffering from these conditions are subject to recurrent fibromyalgia-like pain and anxiety-depressive co-morbidities. With a very different symptomatology, diabetes also has a major impact on society: it is the 7th leading cause of death according to the WHO in 2003, with possibility of serious complications and emergence of negative emotions, as such as anxiety and depression. Like diabetes, ICRs require patients to adopt new behaviors and to maintain them over time. They are then given recommendations about their treatment, as well as about their lifestyle. It can be difficult for them to adhere to these recommendations. Enhancing mindfulness skills can help them to develop positive emotions, coping strategies and acceptance skills, as well as satisfying the psychological needs that are fundamental to their balance. The aim of this thesis is to identify the levers for action among mindfulness skills, satisfaction of basic psychological needs and beliefs about treatment, in order to suggest ways of optimizing patients care for the professionals around of them.Method: The first part of the thesis consisted of adapting, in the chronic disease context, and validating a scale for measuring the satisfaction and frustration of psychological needs derived from the self-determination model (Chen et al., 2015). This tool using 24 items assessed by a 5-point Likert scale, was tested on 2 samples of subjects recruited online: a group of patients with CIR (rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis) and a group of diabetic patients. The psychometric properties of the scale were tested using quantitative analyses based on two theories: the classical test theory, and the theory based on the item response model. The validated scale was then used with other variables of interest, such as mindfulness skills, beliefs about medicine and anxiety-depressive affects, in multiple linear regression analyses to identify their impact on life satisfaction, quality of life, and adherence, in order to propose interventions targeting the identified predictors.Results: The scale, adapted to the context of chronic illness, is a reliable and valid instrument that can be used in both research and clinical practice. It comprises 8 dimensions and distinguishes two populations in relation to patients: their relatives and healthcare professionals. Life satisfaction can be improved by supporting patients’ autonomy, and by taking into account patients depressive affects. Quality of life can be improved by satisfying the need for competence, by reducing depressive affect and the frustration of the need for autonomy and competence. Anxiety affects have an ambivalent impact on quality of life, improving its physical dimension and altering its mental dimension. Adherence to treatment can be improved through mindfulness skills, beliefs about treatment, and by reducing the frustration associated with relationships with relativesConclusion: In order to develop mindfulness skills, to support patient autonomy, and to remove obstacles linked to beliefs of treatment, integrative approaches should be promoted to improve overall patient care
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Chronic inflammatory rheumatisms"

1

Glynn, L. E., and H. D. Schlumberger. Experimental Models of Chronic Inflammatory Diseases. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Glynn, L. E., and H. D. Schlumberger. Experimental Models of Chronic Inflammatory Diseases. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wackenheim, A., and Yves Dirheimer. Craniovertebral Region in Chronic Inflammatory Rheumatic Diseases. Springer London, Limited, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wackenheim, A., and Yves Dirheimer. Craniovertebral Region in Chronic Inflammatory Rheumatic Diseases. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Straub, Rainer. Origin of Chronic Inflammatory Systemic Diseases and Their Sequelae. Elsevier Science & Technology Books, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Straub, Rainer. Origin of Chronic Inflammatory Systemic Diseases and Their Sequelae. Elsevier Science & Technology Books, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rudwaleit, Martin. Enthesitis. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0054.

Full text
Abstract:
Enthesitis is one of the key manifestations of spondyloarthritides (SpA) including ankylosing spondylitis (AS) and psoriatic arthritis. Enthesitis can occur alone or in combination with peripheral arthritis, sacroiliitis, or spondylitis. The inflammatory process is typically located at the insertion of the enthesis or ligament to bone, often resulting in osteitis as well. Because of its anatomical and functional complexity the term 'enthesis organ' has been coined. Biomechanical stress applied to the enthesis seems to play an important role for the occurrence of enthesitis in genetically predisposed individuals. Ultrasound imaging of peripheral entheses reveals enthesis abnormalities including entheseal calcification, bony erosion, or bony proliferation. Power Doppler signals demonstrating increased vascularization of inflamed entheses at the insertional site appear to be the most characteristic finding for enthesitis, yet study results are conflicting. Enthesitis-related osteitis and enthesitis at the spine is best visualized by MRI. Enthesitis may resolve spontaneously or may run a chronic course. Standard treatment includes local steroid injections, non-steroidal anti-inflammatory drugs (NSAIDs), and physical therapy. There is little evidence for the efficacy of disease-modifying anti-rheumatic drugs (DMARDs) in enthesitis. In contrast, anti-TNF agents have proven efficacy, and their use in treatment-resistant enthesitis is recommended in the Assessment of SpondyloArthritis international Society (ASAS)/European League Against Rheumatism (EULAR) recommendations for the management of AS and axial SpA and in the EULAR recommendations for psoriatic arthritis.
APA, Harvard, Vancouver, ISO, and other styles
8

Rudwaleit, Martin. Enthesitis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0054_update_002.

Full text
Abstract:
Enthesitis is one of the key manifestations of spondyloarthritis (SpA) including ankylosing spondylitis (AS) and psoriatic arthritis. Enthesitis can occur alone or in combination with peripheral arthritis, sacroiliitis, or spondylitis. The inflammatory process is typically located at the insertion of the enthesis or ligament to bone, often resulting in osteitis as well. Because of its anatomical and functional complexity the term ’enthesis organ’ has been coined. Biomechanical stress applied to the enthesis seems to play an important role for the occurrence of enthesitis in genetically predisposed individuals. Ultrasound imaging of peripheral entheses reveals enthesis abnormalities including entheseal calcification, bony erosion, or bony proliferation. Power Doppler signals demonstrating increased vascularization of inflamed entheses at the insertional site appear to be the most characteristic finding for enthesitis, yet study results are conflicting. Enthesitis-related osteitis and enthesitis at the spine is best visualized by MRI. Enthesitis may resolve spontaneously or may run a chronic course. Standard treatment includes local steroid injections, non-steroidal anti-inflammatory drugs (NSAIDs), and physical therapy. There is little evidence for the efficacy of disease-modifying antirheumatic drugs (DMARDs) in enthesitis. In contrast, anti-TNF agents have proven efficacy, and their use in treatment-resistant enthesitis is recommended in the Assessment of SpondyloArthritis international Society (ASAS)/European League Against Rheumatism (EULAR) recommendations for the management of AS and axial SpA and in the EULAR recommendations for psoriatic arthritis.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Chronic inflammatory rheumatisms"

1

Vogler, D., G. Schmittat, and S. Ohrndorf. "Rheumatism and wIRA Therapy." In Water-filtered Infrared A (wIRA) Irradiation, 225–32. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-92880-3_19.

Full text
Abstract:
AbstractRheumatologic disorders comprise various conditions having different etiologies and pathogenesis, the leading clinical symptoms of which are chronic joint pain and musculoskeletal impairment. In the context of a multimodal therapy concept, the use of hyperthermia (HT) is a classical and developing adjuvant symptomatic treatment option. wIRA is an effective and well-established variant of thermal therapy in different rheumatologic disorders. This article summarizes the current state of research into locally applied wIRA in the field of rheumatism and rheumatological diseases.Local and serially applied wIRA significantly relieves pain in patients with axial spondyloarthritis (axSpA), osteoarthritis (OA) and fibromyalgia (FM), which, at least reduces the requirement for analgesics and has positive effects on well-being, functional status or disease activity. wIRA has been shown to reduce levels of C-reactive protein (CRP) and proinflammatory cytokine tumour necrosis factor α (TNFα). Given its safety and tolerability, wIRA is highly amenable in combination with standard therapies.Currently, wIRA effects are assessed in OA patients, non-inflammatory arthralgia and recent-onset arthritis of the hands. Preliminary data on effects on pain, global disease burden and functional status are promising. The potential value of wIRA, for e.g., Raynaud’s phenomena and sclerotic skin changes, need further evaluation.
APA, Harvard, Vancouver, ISO, and other styles
2

Rudwaleit, Martin. "Enthesitis." In Oxford Textbook of Rheumatology, 398–403. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0054_update_003.

Full text
Abstract:
Enthesitis is one of the key manifestations of spondyloarthritis (SpA) including ankylosing spondylitis (AS) and psoriatic arthritis. Enthesitis can occur alone or in combination with peripheral arthritis, sacroiliitis, or spondylitis. The inflammatory process is typically located at the insertion of the enthesis or ligament to bone, often resulting in osteitis as well. Because of its anatomical and functional complexity the term ’enthesis organ’ has been coined. Biomechanical stress applied to the enthesis seems to play an important role for the occurrence of enthesitis in genetically predisposed individuals. Ultrasound imaging of peripheral entheses reveals enthesis abnormalities including entheseal calcification, bony erosion, or bony proliferation. Power Doppler signals demonstrating increased vascularization of inflamed entheses at the insertional site appear to be the most characteristic finding for enthesitis, yet study results are conflicting. Enthesitis-related osteitis and enthesitis at the spine is best visualized by MRI. Enthesitis may resolve spontaneously or may run a chronic course. Standard treatment includes local steroid injections, non-steroidal anti-inflammatory drugs (NSAIDs), and physical therapy. There is little evidence for the efficacy of disease-modifying antirheumatic drugs (DMARDs) in enthesitis. In contrast, anti-TNF agents and other biologics have proven efficacy, and their use in treatment-resistant enthesitis is recommended in the Assessment of SpondyloArthritis international Society (ASAS)/European League Against Rheumatism (EULAR) recommendations for the management of AS and axial SpA and in the EULAR recommendations for psoriatic arthritis.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Chronic inflammatory rheumatisms"

1

Zaher, S., K. Nassar, A. Ajerouassi, and S. Janani. "AB1523 TUBERCULOSIS UNDER BIOTHERAPY IN CHRONIC INFLAMMATORY RHEUMATISMS: A COHORT STUDY." In EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.2519.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Carine, SAVEL, Marie Sophie Cherillat, Anne Marie Tronche, Pauline Berland, Candy Guiguet-Auclair, Martin Soubrier, Laurent Gerbaud, and Sandrine Malochet. "THU0731-HPR “OSER ABORDER” SURVEY ON THE CROSSED NEEDS OF A BETTER UNDERSTANDING OF SEXUAL HEALTH ISSUES BETWEEN PATIENTS SUFFERING FROM CHRONIC INFLAMMATORY RHEUMATISMS AND HEALTHCARE PROFESSIONALS INVOLVED IN PATIENT THERAPEUTIC EDUCATION." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.827.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Abla, Hedia Ben, Sonia Rekik, Samia Jammali, Soumaya Boussaid, Hela Sahli, Elhem Cheour, and Mohamed Elleuch. "AB0299 COXITIS DURING CHRONIC INFLAMMATORY RHEUMATISM." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.3829.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Henry, I. Monjo, F. De la Calle, E. Trigo, E. Fernandez, D. Benavent, E. De Miguel, and A. Balsa. "SAT0634 Musculoskeletal ultrasound in patients with chronic inflammatory rheumatism post-chikungunya." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.6702.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Trouvin, A.-P., C. Beller, P. Preiss, and S. Perrot. "FRI0697 French nationwide survey of chronic pain perception in 1739 patients with chronic inflammatory rheumatism." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.5781.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Amouzougan, A. S., H. Marotte, K. Boussoualim, L. Mijola, P. Collet, B. Pallot-Prades, N. Prévot-Bitot, F. G. Barral, and T. Thomas. "AB1169 Can ultrasound-detected synovitis predict radionuclide synovectomy efficacy in chronic inflammatory rheumatism?" In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.6850.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rossi-Semerano, Linda, Perrine Dusser, Margarete Lima, Isabelle Marie, Fatima Benleulmi, William Fahy, Isabelle Koné-Paut, and Chrystelle Hascoet. "SAT0514 MIRAJE: A TRANSVERSAL THERAPEUTIC EDUCATION PROGRAM FOR CHILDREN AND ADOLESCENTS WITH CHRONIC INFLAMMATORY RHEUMATISM." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.6939.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Boissinot, L., L. Gutermann, M. Dormeuil, AP Trouvin, J. Avouac, F. Chast, and O. Conort. "DI-057 Patients with chronic inflammatory rheumatism: evaluation of their knowledge on disease modifying antirheumatic drugs." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.304.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

IMEN, BENCHARIF, and Dalila Bendjenna. "AB1340 IMPACT OF THERAPEUTIC PATIENT EDUCATION ON THE SAFETY OF PATIENTS ON BIOTHERAPY FOR CHRONIC INFLAMMATORY RHEUMATISM." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.5159.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dusser, Perrine, Chrystelle Hascoet, Isabelle Koné-Paut, and Linda Rossi-Semerano. "THU0535 NATURE AND IMPACT OF THE FRENCH NETWORK RESRIP ON SCHOOLING, FOR CHILDREN WITH CHRONIC INFLAMMATORY RHEUMATISM." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.7122.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Chronic inflammatory rheumatisms' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography